Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -2.221 | 2.676 | 0.99986 | 1.00000 | |
RegionR2 | 6.274 | 2.676 | 0.00153 | 0.02921 | Specific for R2: 6.925 |
RegionR3 | 0.747 | 2.676 | 0.46458 | 0.97296 | |
RegionR4 | -1.273 | 2.676 | 0.94603 | 1.00000 | |
RegionR5 | -0.094 | 2.676 | 0.70413 | 1.00000 | |
RegionR6 | 1.658 | 2.676 | 0.22201 | 0.80225 | |
RegionR7 | -3.071 | 2.676 | 0.99976 | 1.00000 | |
RegionR8 | -2.021 | 2.676 | 0.99973 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | 4.255 | 2.676 | 0.48363 | 1.00000 | |
RegenerationR2 | -2.384 | 2.676 | 0.00138 | 0.05569 | |
RegenerationR3 | -0.747 | 2.676 | 0.55594 | 0.88653 | |
RegenerationR4 | -1.124 | 2.676 | 0.77076 | 0.97686 | |
RegenerationR5 | -0.393 | 2.676 | 0.84153 | 1.00000 | |
RegenerationR6 | -0.061 | 2.676 | 0.92150 | 1.00000 | |
RegenerationBL | -2.944 | 2.676 | 0.99973 | 1.00000 | |
RegenerationTP | -1.024 | 2.676 | 1.00000 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_18140 | 171 | 3.56 | Mlig455_033232 | Neo: - Age: Up-Down-Down Region-specific R2: 6.925 Region-enriched R2: 6.274/0.02921 |
TRPC5 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_033232 {REF} {Length: 4524} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.2]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.5]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=742, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=745, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=742, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=696, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1016, Expect=0.0]} {RNA1509_34138} {RNA1310_12839} {RNA815_17637} |
2. | MligTC455_18139 | 70 | 1.45 | Mlig455_010809 | Neo: - Age: logFC(26M/2M)=-0.809 Region-enriched R2: 6.868/0.00081 |
TRPC5 | 5.782 | 0.994 | 0.992 | 0.926 | 0.980 | 0.906 | 0.984 | Mlig455_010809 {REF} {Length: 4442} {Pfam: Ion transport protein [PF00520.33, score=98.6]; Transient receptor ion channel II [PF08344.13, score=94.3]; Polycystin cation channel [PF08016.14, score=49.0]; Ankyrin repeats (many copies) [PF13637.8, score=37.1]; Ankyrin repeats (3 copies) [PF12796.9, score=33.2]; Ankyrin repeat [PF13606.8, score=25.4]; Ankyrin repeats (many copies) [PF13857.8, score=24.1]; Ankyrin repeat [PF00023.32, score=23.2]} {Human: ENSG00000072315, TRPC5, transient receptor potential cation channel subfamily C member 5, [RH, Score=743, Expect=0.0]; ENSG00000133107, TRPC4, transient receptor potential cation channel subfamily C member 4, [RH, Score=740, Expect=0.0]} {Mouse: ENSMUSG00000041710, Trpc5, transient receptor potential cation channel, subfamily C, member 5, [RH, Score=744, Expect=0.0]; ENSMUSG00000027748, Trpc4, transient receptor potential cation channel, subfamily C, member 4, [RH, Score=740, Expect=0.0]} {Dmel: FBgn0032593, Trpgamma, Transient receptor potential cation channel gamma, [RH, Score=848, Expect=0.0]} {Celegans: WBGene00006615, trp-2, TRP (Transient receptor potential) channel family; TRP homlogous cation channel protein, [RH, Score=694, Expect=0.0]} {Smed: dd_Smed_v6_20495_0_1, dd_Smed_v6_20495_0_1, [RH, Score=1017, Expect=0.0]} {RNA1509_34138} {RNA1310_12839, RNA1509_34138} {RNA1509_34138, RNA815_17637} |
3. | MligTC455_12269 | 42 | 0.88 | Mlig455_062448 | Neo: - Age: - Region-enriched R2: 6.351/0.02912 |
5.671 | 0.993 | 0.986 | 0.863 | 0.990 | 0.851 | 0.988 | Mlig455_062448 {REF} {Length: 941} {RNA1310_43338} {RNA815_24238} | |
4. | MligTC455_52507 | 60 | 1.26 | Mlig455_016440 | Neo: - Age: - Region-enriched R2: 5.871/0.01204 |
5.431 | 0.870 | 0.928 | 0.953 | 0.825 | 0.898 | 0.957 | Mlig455_016440 {REF} {Length: 1576} {Pfam: PAN domain [PF00024.28, score=19.3]} {RNA1310_98267} | |
5. | MligTC455_19249 | 90 | 1.86 | Mlig455_054092 | Neo: - Age: Down-Up-Up Region-enriched R2: 7.298/0.00139 |
5.378 | 0.908 | 0.802 | 0.861 | 0.957 | 0.914 | 0.936 | Mlig455_054092 {REF} {Length: 667} {TRANSSPLICED} {RNA1509_57448} {RNA1310_51394, RNA1509_57448} {RNA1509_57448, RNA815_26076} | |
6. | MligTC455_17363 | 62 | 1.28 | Mlig455_003936 | Neo: - Age: - |
5.336 | 0.771 | 0.990 | 0.744 | 0.965 | 0.878 | 0.988 | Mlig455_003936 {REF} {Length: 1252} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=45.9]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=26.4]} {RNA1310_47889} {RNA815_24646} | |
7. | MligTC455_42520 | 221 | 4.6 | Mlig455_051277 | Neo: - Age: Down-Up-Up Region-specific R2: 7.331 Region-enriched R2: 7.171/0.00000 Regeneration-downregulated R2: -3.384 Regeneration-depleted R2: -3.384 |
5.283 | 0.770 | 0.935 | 0.894 | 0.953 | 0.737 | 0.994 | Mlig455_051277 {REF} {Length: 969} {RNA1310_42329} {RNA815_20649} | |
8. | MligTC455_44966 | 574 | 11.95 | Mlig455_036578, Mlig455_057773 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.756 Region-specific R2: 7.016 Region-enriched R2: 7.690/0.00000 |
5.27 | 0.782 | 0.795 | 0.846 | 0.963 | 0.895 | 0.989 | Mlig455_036578 {REF} {Length: 1101} {RNA1509_34765} {RNA1310_57079} {RNA815_29388} Mlig455_057773 {REF} {Length: 629} {RNA1509_34765} {RNA1310_57079, RNA1509_34765} {RNA1509_34765, RNA815_29388} |
|
9. | MligTC455_35739 | 91 | 1.9 | Mlig455_050779 | Neo: - Age: Up-Down-Down |
ADGRL2 | 5.148 | 0.811 | 0.802 | 0.728 | 0.985 | 0.899 | 0.923 | Mlig455_050779 {REF} {Length: 4277} {Pfam: 7 transmembrane receptor (Secretin family) [PF00002.26, score=110.1]; Pentaxin family [PF00354.19, score=43.4]; Hormone receptor domain [PF02793.24, score=35.9]; Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=33.0]; GPCR-Autoproteolysis INducing (GAIN) domain [PF16489.7, score=20.5]; Myc amino-terminal region [PF01056.20, score=18.8]} {Human: ENSG00000117114, ADGRL2, adhesion G protein-coupled receptor L2, [RH, Score=140, Expect=5e-33]; ENSG00000072071, ADGRL1, adhesion G protein-coupled receptor L1, [RH, Score=139, Expect=2e-32]; ENSG00000150471, ADGRL3, adhesion G protein-coupled receptor L3, [RH, Score=133, Expect=9e-31]} {Mouse: ENSMUSG00000028184, Adgrl2, adhesion G protein-coupled receptor L2, [RH, Score=142, Expect=1e-33]; ENSMUSG00000013033, Adgrl1, adhesion G protein-coupled receptor L1, [RH, Score=140, Expect=6e-33]} {Celegans: WBGene00002252, lat-2, Latrophilin-like protein LAT-2, [RH, Score=124, Expect=2e-28]} {Smed: dd_Smed_v6_16446_0_2, dd_Smed_v6_16446_0_2, [RH, Score=444, Expect=1e-139]} {RNA1509_25495} {RNA1310_3070} {RNA815_2153} |
10. | MligTC455_13902 | 400 | 8.32 | Mlig455_011022, Mlig455_011835, Mlig455_013117 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.562 Region-specific R2: 6.064 Region-enriched R2: 5.080/0.00072 |
4.779 | - | 0.978 | 0.982 | 0.962 | 0.900 | 0.957 | Mlig455_011022 {REF} {Length: 631} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_011835 {REF} {Length: 2387} {RNA1509_28527} {RNA1310_38436.1} {RNA815_28856} Mlig455_013117 {REF} {Length: 1663} {NoTransDecoderORF} {RNA1310_40518} {RNA815_20411.2} |
|
11. | MligTC455_43137 | 118 | 2.46 | Mlig455_043159 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.878 Region-enriched R2: 5.988/0.00166 |
4.754 | 0.980 | 0.991 | 0.985 | 0.952 | 0.846 | - | Mlig455_043159 {REF} {Length: 1651} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=25.7]} {RNA1509_48871} {RNA1310_23692, RNA1509_48871} {RNA1509_48871, RNA815_11317} | |
12. | MligTC455_45811 | 216 | 4.5 | Mlig455_015628 | Neo: - Age: Down-Up-Down Region-enriched R2: 5.807/0.00004 |
4.71 | - | 0.955 | 0.950 | 0.980 | 0.840 | 0.985 | Mlig455_015628 {REF} {Length: 1061} {RNA1310_43338} {RNA815_24238} | |
13. | MligTC455_10226 | 119 | 2.48 | Mlig455_023508, Mlig455_023518, Mlig455_023617 | Neo: - Age: - |
4.638 | 0.821 | 0.991 | 0.975 | 0.954 | 0.897 | - | Mlig455_023508 {REF} {Length: 1311} {RNA1310_22533.2} {RNA815_23050} Mlig455_023518 {REF} {Length: 1413} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.5]} {RNA1310_22533.2} {RNA815_23050} Mlig455_023617 {REF} {Length: 1414} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.6]} {RNA1310_22533.2} {RNA815_23050} |
|
14. | MligTC455_13903 | 648 | 13.5 | Mlig455_013116 | Neo: - Age: logFC(26M/2M)=-1.026 Region-specific R2: 6.980 Region-enriched R2: 7.338/0.00000 |
4.579 | - | 0.991 | 0.827 | 0.883 | 0.885 | 0.993 | Mlig455_013116 {REF} {Length: 914} {RNA1509_28527} {RNA1310_38436.2, RNA1509_28527} {RNA1509_28527, RNA815_28856} | |
15. | MligTC455_30160 | 55 | 1.15 | Mlig455_035128 | Neo: - Age: - Region-enriched R2: 5.270/0.01686 |
TCF7L1 | 4.553 | 0.973 | 0.819 | - | 0.985 | 0.864 | 0.912 | Mlig455_035128 {REF} {Length: 2946} {Pfam: HMG (high mobility group) box [PF00505.21, score=79.2]; HMG-box domain [PF09011.12, score=34.5]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=1e-42]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=7e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=2e-41]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=8e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=158, Expect=9e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=156, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=6e-48]} {RNA1509_46571} {RNA1310_11181} {RNA815_36690} |
16. | MligTC455_08408 | 41 | 0.86 | Mlig455_043171 | Neo: - Age: Up-Down-Down |
4.545 | 0.771 | 0.991 | 0.969 | 0.952 | 0.862 | - | Mlig455_043171 {REF} {Length: 1568} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=19.4]} {RNA1310_47844} {RNA815_49360} | |
17. | MligTC455_54282 | 74 | 1.54 | Mlig455_020191 | Neo: - Age: - |
4.544 | 0.848 | 0.936 | - | 0.946 | 0.838 | 0.976 | Mlig455_020191 {REF} {Length: 937} {RNA1509_48973} {RNA1310_40738.2} {RNA815_31898} | |
18. | MligTC455_10228 | 50 | 1.05 | Mlig455_023553 | Neo: - Age: - |
4.541 | 0.801 | 0.991 | 0.897 | 0.955 | 0.897 | - | Mlig455_023553 {REF} {Length: 1195} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=20.0]} {RNA1310_22533.1} {RNA815_23050} | |
19. | MligTC455_40040 | 365 | 7.61 | Mlig455_008332 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.784 Region-specific R2: 6.834 Region-enriched R2: 5.705/0.00005 |
4.53 | 0.815 | 0.961 | - | 0.987 | 0.877 | 0.890 | Mlig455_008332 {REF} {Length: 707} {RNA1509_39735} {RNA1310_73916, RNA1509_39735} {RNA1509_39735, RNA815_42730.2} | |
20. | MligTC455_41443 | 382 | 7.96 | Mlig455_034791, Mlig455_034803 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-1.360 Region-enriched R2: 5.869/0.00205 |
4.525 | 0.712 | 0.994 | 0.922 | 0.952 | 0.945 | - | Mlig455_034791 {REF} {Length: 996} {RNA1310_39610.1} {RNA815_26421} Mlig455_034803 {REF} {Length: 1084} {RNA1310_39610.1} {RNA815_26421} |
|
21. | MligTC455_41854 | 80 | 1.67 | Mlig455_034307, Mlig455_067305, Mlig455_067321 | Neo: - Age: - |
4.506 | 0.934 | 0.836 | 0.883 | 0.954 | 0.899 | - | Mlig455_034307 {REF} {Length: 459} {RNA815_51696.1} Mlig455_067305 {REF} {Length: 466} {RNA815_51696.1} Mlig455_067321 {REF} {Length: 95} {TRANSSPLICED} {NoTransDecoderORF} {RNA815_51696.1} |
|
22. | MligTC455_25073 | 1271 | 26.47 | Mlig455_015905 | Neo: - Age: logFC(26M/2M)=-0.947 Region-specific R2: 3.291 Region-enriched R2: 2.110/0.00052 |
PI16 | 4.5 | 0.875 | 0.816 | - | 0.945 | 0.955 | 0.909 | Mlig455_015905 {REF} {Length: 2189} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=111, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=7e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.1, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=3e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_36129, RNA1509_46021, RNA1509_5027} {RNA1310_1356.1, RNA1509_36129, RNA1509_46021} {RNA1509_36129, RNA1509_46021, RNA815_4508} |
23. | MligTC455_53546 | 130 | 2.72 | Mlig455_013326, Mlig455_013334 | Neo: - Age: - Region-enriched R2: 6.753/0.01892 |
MMP9 | 4.492 | 0.969 | - | 0.703 | 0.954 | 0.908 | 0.958 | Mlig455_013326 {REF} {Length: 1449} {Pfam: Fibronectin type II domain [PF00040.21, score=92.5]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=87.8, Expect=3e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=82.4, Expect=1e-16]; ENSMUSG00000031740, Mmp2, matrix metallopeptidase 2, [RH, Score=78.6, Expect=2e-15]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [RH, Score=138, Expect=3e-38]} {RNA1310_38631} {RNA815_51136} Mlig455_013334 {REF} {Length: 1398} {Pfam: Fibronectin type II domain [PF00040.21, score=92.1]} {Human: ENSG00000100985, MMP9, matrix metallopeptidase 9, [RH, Score=89.4, Expect=1e-18]} {Mouse: ENSMUSG00000017737, Mmp9, matrix metallopeptidase 9, [RH, Score=84.0, Expect=4e-17]} {Smed: dd_Smed_v6_12601_0_1, dd_Smed_v6_12601_0_1, [RH, Score=140, Expect=2e-38]} {RNA1310_38631} {RNA815_51136} |
24. | MligTC455_19875 | 82 | 1.71 | Mlig455_024408 | Neo: - Age: Down-Up-Down |
4.489 | 0.865 | - | 0.853 | 0.976 | 0.880 | 0.915 | Mlig455_024408 {REF} {Length: 2479} {Pfam: CD20-like family [PF04103.17, score=40.9]} {Mouse: ENSMUSG00000048004, Tmem196, transmembrane protein 196, [Score=63.5, Expect=2e-12]} {Smed: dd_Smed_v6_14043_0_1, dd_Smed_v6_14043_0_1, [Score=184, Expect=5e-59]} {RNA1509_25506} {RNA1310_4968.1} {RNA815_23744} | |
25. | MligTC455_35802 | 114 | 2.38 | Mlig455_051876, Mlig455_051902, Mlig455_053140 | Neo: - Age: - |
CACNA2D1 | 4.485 | 0.736 | 0.943 | - | 0.928 | 0.889 | 0.989 | Mlig455_051876 {REF} {Length: 3144} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=89.1]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=84.7, Expect=2e-16]} {RNA1509_55590} {RNA1310_60852} {RNA815_15380} Mlig455_051902 {REF} {Length: 4662} {Pfam: VWA N-terminal [PF08399.13, score=90.4]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.6]; von Willebrand factor type A domain [PF00092.30, score=38.6]; Cache domain [PF02743.20, score=27.5]; von Willebrand factor type A domain [PF13519.8, score=26.5]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [RH, Score=326, Expect=8e-94]} {Mouse: ENSMUSG00000040118, Cacna2d1, calcium channel, voltage-dependent, alpha2/delta subunit 1, [RH, Score=326, Expect=7e-94]} {Dmel: FBgn0261041, stj, straightjacket, [Score=229, Expect=7e-61]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=141, Expect=9e-34]} {Smed: dd_Smed_v6_19048_0_1, dd_Smed_v6_19048_0_1, [Score=153, Expect=1e-37]} {RNA1509_55590} {RNA1310_7325.1, RNA1509_55590} {RNA1509_55590, RNA815_14878} Mlig455_053140 {REF} {Length: 3265} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=87.9]} {Human: ENSG00000153956, CACNA2D1, calcium voltage-gated channel auxiliary subunit alpha2delta 1, [Score=87.0, Expect=8e-17]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=50.4, Expect=9e-06]} {RNA1509_55590} {RNA1310_7325.1} {RNA815_14878} |
26. | MligTC455_46430 | 62 | 1.29 | Mlig455_057117, Mlig455_069301 | Neo: - Age: - |
GUCY2F | 4.476 | 0.921 | 0.706 | - | 0.981 | 0.883 | 0.985 | Mlig455_057117 {REF} {Length: 2651} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=196.0]; Nitrate and nitrite sensing [PF08376.12, score=82.5]; Heme NO binding associated [PF07701.16, score=28.2]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=247, Expect=9e-70]; ENSG00000169418, NPR1, natriuretic peptide receptor 1, [Score=242, Expect=3e-68]; ENSG00000159899, NPR2, natriuretic peptide receptor 2, [Score=238, Expect=5e-67]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=246, Expect=7e-70]; ENSMUSG00000027931, Npr1, natriuretic peptide receptor 1, [Score=242, Expect=2e-68]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=241, Expect=7e-68]; ENSMUSG00000028469, Npr2, natriuretic peptide receptor 2, [Score=239, Expect=3e-67]} {Dmel: FBgn0053958, CG33958, [Score=266, Expect=4e-79]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=235, Expect=3e-66]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=238, Expect=4e-67]} {RNA1509_38781} {RNA1310_35456} {RNA815_22108} Mlig455_069301 {REF} {Length: 2370} {Pfam: Adenylate and Guanylate cyclase catalytic domain [PF00211.22, score=178.1]; Nitrate and nitrite sensing [PF08376.12, score=82.3]; Heme NO binding associated [PF07701.16, score=28.0]} {Human: ENSG00000101890, GUCY2F, guanylate cyclase 2F, retinal, [Score=232, Expect=2e-64]} {Mouse: ENSMUSG00000042282, Gucy2f, guanylate cyclase 2f, [Score=232, Expect=1e-64]; ENSMUSG00000020890, Gucy2e, guanylate cyclase 2e, [Score=225, Expect=5e-62]} {Dmel: FBgn0053958, CG33958, [Score=250, Expect=5e-73]} {Celegans: WBGene00001547, gcy-22, Receptor-type guanylate cyclase gcy-22, [Score=223, Expect=1e-61]} {Smed: dd_Smed_v6_14331_0_1, dd_Smed_v6_14331_0_1, [Score=221, Expect=4e-61]} {RNA1509_38781} {RNA1310_35456} {RNA815_24181} |
27. | MligTC455_14483 | 140 | 2.92 | Mlig455_028240 | Neo: - Age: - Region-enriched R2: 6.203/0.04837 |
4.449 | 0.771 | 0.877 | - | 0.953 | 0.865 | 0.983 | Mlig455_028240 {REF} {Length: 728} {RNA1310_111517} {RNA815_9716} | |
28. | MligTC455_49824 | 466 | 9.71 | Mlig455_036536 | Neo: - Age: - Region-specific R2: 4.841 Region-enriched R2: 3.862/0.00010 |
4.431 | 0.806 | - | 0.746 | 0.977 | 0.918 | 0.984 | Mlig455_036536 {REF} {Length: 1139} {Pfam: Nucleoporin FG repeat region [PF13634.8, score=21.2]} {Celegans: WBGene00003748, nlp-10, Neuropeptide-Like Protein, [RH, Score=49.3, Expect=7e-08]} {RNA1509_18714, RNA1509_59524} {RNA1310_41906, RNA1509_18714, RNA1509_59524} {RNA1509_18714, RNA1509_59524, RNA815_24488} | |
29. | MligTC455_30159 | 107 | 2.22 | Mlig455_008465, Mlig455_009916 | Neo: - Age: Up-Down-Down Region-enriched R2: 4.961/0.00498 |
TCF7L1 | 4.423 | 0.870 | 0.842 | - | 0.954 | 0.861 | 0.896 | Mlig455_008465 {REF} {Length: 2454} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.3]; HMG-box domain [PF09011.12, score=34.6]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=7e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=156, Expect=8e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=161, Expect=4e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=4e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=6e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=4e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=2e-48]} {RNA1310_11181} {RNA815_36690} Mlig455_009916 {REF} {Length: 2137} {Pfam: HMG (high mobility group) box [PF00505.21, score=81.4]; HMG-box domain [PF09011.12, score=34.7]} {Human: ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=161, Expect=4e-43]; ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=2e-43]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=157, Expect=5e-42]} {Mouse: ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=162, Expect=2e-43]; ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=159, Expect=3e-44]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=155, Expect=4e-43]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=157, Expect=3e-41]} {Celegans: WBGene00004077, pop-1, [Score=108, Expect=2e-25]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=166, Expect=1e-48]} {RNA1310_11181} {RNA815_36690} |
30. | MligTC455_18333 | 273 | 5.7 | Mlig455_010935 | Neo: - Age: Down-Up-Up Region-enriched R2: 5.059/0.00307 |
4.422 | 0.816 | 0.794 | - | 0.963 | 0.870 | 0.979 | Mlig455_010935 {REF} {Length: 510} {RNA1310_33328.2} {RNA815_15093.1} | |
31. | MligTC455_15184 | 33 | 0.69 | Mlig455_065087 | Neo: - Age: - |
4.42 | 0.971 | - | 0.770 | 0.823 | 0.895 | 0.961 | Mlig455_065087 {REF} {Length: 2555} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=183.3]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=48.5, Expect=1e-05]} {Celegans: WBGene00009073, delm-1, DEgenerin Linked to Mechanosensation, [Score=68.2, Expect=1e-11]} {Smed: dd_Smed_v6_37545_0_1, dd_Smed_v6_37545_0_1, [RH, Score=125, Expect=3e-30]} {RNA1310_11413} {RNA815_11497} | |
32. | MligTC455_40687 | 28 | 0.58 | Mlig455_040563, Mlig455_062078 | Neo: - Age: - |
PDE1C | 4.397 | 0.877 | - | 0.713 | 0.950 | 0.896 | 0.961 | Mlig455_040563 {REF} {Length: 1798} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.1]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.0]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=362, Expect=2e-117]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=358, Expect=2e-117]} {Mouse: ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=362, Expect=5e-118]; ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=362, Expect=7e-120]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=346, Expect=4e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_21546_0_1, dd_Smed_v6_21546_0_1, [Score=396, Expect=7e-133]} {RNA1310_80402} Mlig455_062078 {REF} {Length: 1807} {Pfam: 3'5'-cyclic nucleotide phosphodiesterase [PF00233.21, score=268.6]; 3'5'-cyclic nucleotide phosphodiesterase N-terminal [PF08499.14, score=29.1]} {Human: ENSG00000154678, PDE1C, phosphodiesterase 1C, [Score=356, Expect=3e-115]; ENSG00000115252, PDE1A, phosphodiesterase 1A, [Score=355, Expect=5e-116]} {Mouse: ENSMUSG00000059173, Pde1a, phosphodiesterase 1A, calmodulin-dependent, [Score=359, Expect=1e-118]; ENSMUSG00000004347, Pde1c, phosphodiesterase 1C, [Score=356, Expect=8e-116]} {Dmel: FBgn0264815, Pde1c, Phosphodiesterase 1c, [Score=347, Expect=2e-108]} {Celegans: WBGene00011433, pde-1, Probable 3',5'-cyclic phosphodiesterase pde-1, [Score=347, Expect=3e-113]} {Smed: dd_Smed_v6_26758_0_1, dd_Smed_v6_26758_0_1, [Score=394, Expect=3e-132]} {RNA1509_46211} {RNA1310_80402} {RNA815_55704} |
33. | MligTC455_15467 | 225 | 4.69 | Mlig455_000546 | Neo: - Age: Down-Up-Up Region-specific R2: 6.857 Region-enriched R2: 5.997/0.00105 |
4.387 | 0.951 | - | 0.760 | 0.961 | 0.893 | 0.822 | Mlig455_000546 {REF} {Length: 844} {Pfam: Pancreatic hormone peptide [PF00159.20, score=42.9]} {Smed: dd_Smed_v6_16946_0_1, dd_Smed_v6_16946_0_1, [Score=39.7, Expect=1e-05]} {RNA1310_53697} {RNA815_26198} | |
34. | MligTC455_09874 | 31 | 0.65 | Mlig455_045071 | Neo: - Age: - |
DOC2A | 4.357 | 0.837 | 0.991 | 0.700 | 0.933 | 0.896 | - | Mlig455_045071 {REF} {Length: 1760} {Pfam: C2 domain [PF00168.32, score=55.9]} {Human: ENSG00000149927, DOC2A, double C2 domain alpha, [Score=55.8, Expect=7e-08]} {Mouse: ENSMUSG00000052301, Doc2a, double C2, alpha, [Score=55.5, Expect=7e-08]} {Celegans: WBGene00004923, snt-3, SyNapTotagmin, [Score=70.5, Expect=2e-13]} {Smed: dd_Smed_v6_16731_0_1, dd_Smed_v6_16731_0_1, [Score=112, Expect=7e-27]} {RNA1310_36283} {RNA815_40844} |
35. | MligTC455_50927 | 254 | 5.29 | Mlig455_070541, Mlig455_070562 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.296 Region-enriched R2: 7.883/0.00008 |
FZD4 | 4.355 | 0.763 | - | 0.920 | 0.899 | 0.802 | 0.971 | Mlig455_070541 {REF} {Length: 3522} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=471, Expect=6e-159]} {RNA1509_15834} {RNA1310_3800, RNA1509_15834} {RNA1509_15834, RNA815_19571} Mlig455_070562 {REF} {Length: 3527} {Pfam: Frizzled/Smoothened family membrane region [PF01534.19, score=339.1]; Fz domain [PF01392.24, score=88.1]} {Human: ENSG00000174804, FZD4, frizzled class receptor 4, [RH, Score=446, Expect=1e-149]} {Mouse: ENSMUSG00000049791, Fzd4, frizzled class receptor 4, [RH, Score=446, Expect=2e-149]} {Dmel: FBgn0001085, fz, frizzled, [Score=315, Expect=3e-98]} {Celegans: WBGene00000478, cfz-2, Frizzled-2, [Score=284, Expect=5e-87]} {Smed: dd_Smed_v6_7210_0_1, dd_Smed_v6_7210_0_1, [RH, Score=470, Expect=8e-159]} {RNA1509_15834} {RNA1310_3800} {RNA815_19571} |
36. | MligTC455_50694 | 602 | 12.54 | Mlig455_058794, Mlig455_070066 | Neo: - Age: Down-Down-Up Region-specific R2: 5.478 Region-enriched R2: 3.805/0.01454 |
4.351 | 0.775 | - | 0.722 | 0.973 | 0.900 | 0.981 | Mlig455_058794 {REF} {Length: 776} {RNA1310_76208} {RNA815_49041} Mlig455_070066 {REF} {Length: 781} {RNA1310_76208} {RNA815_49041} |
|
37. | MligTC455_53415 | 319 | 6.64 | Mlig455_053444 | Neo: - Age: Up-Down-Down Region-specific R2: 4.862 Region-enriched R2: 4.179/0.00011 |
RP1 | 4.349 | 0.769 | - | 0.844 | 0.867 | 0.914 | 0.955 | Mlig455_053444 {REF} {Length: 4944} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.3]; Doublecortin [PF03607.19, score=100.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.5]; Fibroblast growth factor [PF00167.20, score=18.6]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=471, Expect=6e-145]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=453, Expect=3e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.9, Expect=1e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=691, Expect=0.0]} {RNA1509_59703} {RNA1310_2710} {RNA815_17469} |
38. | MligTC455_19716 | 35 | 0.73 | Mlig455_008148 | Neo: - Age: - |
NPY1R | 4.344 | 0.724 | 0.703 | 0.994 | 0.941 | - | 0.982 | Mlig455_008148 {REF} {Length: 3212} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=183.4]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=46.8]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=36.4]} {Human: ENSG00000164128, NPY1R, neuropeptide Y receptor Y1, [RH, Score=167, Expect=8e-47]} {Mouse: ENSMUSG00000031932, Gpr83, G protein-coupled receptor 83, [RH, Score=170, Expect=8e-48]; ENSMUSG00000036437, Npy1r, neuropeptide Y receptor Y1, [RH, Score=167, Expect=7e-47]} {Dmel: FBgn0036934, sNPF-R, short neuropeptide F receptor, [RH, Score=256, Expect=1e-78]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [RH, Score=220, Expect=3e-67]} {Smed: dd_Smed_v6_10020_0_1, dd_Smed_v6_10020_0_1, [RH, Score=336, Expect=1e-112]} {RNA1310_21371} {RNA815_7986} |
39. | MligTC455_25703 | 225 | 4.7 | Mlig455_017402, Mlig455_030916 | Neo: - Age: - |
4.335 | 0.771 | 0.933 | 0.865 | 0.956 | 0.810 | - | Mlig455_017402 {REF} {Length: 899} {RNA1310_52753} {RNA815_26527} Mlig455_030916 {REF} {Length: 700} {RNA1310_52753} {RNA815_26527} |
|
40. | MligTC455_44025 | 591 | 12.31 | Mlig455_050980 | Neo: - Age: - Region-specific R2: 5.366 Region-enriched R2: 5.986/0.00000 |
4.328 | 0.975 | - | 0.776 | 0.796 | 0.923 | 0.858 | Mlig455_050980 {REF} {Length: 587} {Smed: dd_Smed_v6_2575_0_1, dd_Smed_v6_2575_0_1, [Score=49.7, Expect=7e-09]} {RNA1509_52032} {RNA1310_52449.2} {RNA815_56904} | |
41. | MligTC455_50172 | 243 | 5.05 | Mlig455_067182 | Neo: - Age: Down-Up-Up Region-specific R2: 6.036 Region-enriched R2: 6.524/0.00000 |
4.327 | 0.733 | - | 0.871 | 0.965 | 0.857 | 0.901 | Mlig455_067182 {REF} {Length: 638} {Pfam: Pancreatic hormone peptide [PF00159.20, score=47.5]} {RNA1509_60030} {RNA1310_56761, RNA1509_60030} {RNA1509_60030, RNA815_31877.1} | |
42. | MligTC455_12102 | 59 | 1.23 | Mlig455_041538, Mlig455_053099 | Neo: - Age: - Region-enriched R2: 6.626/0.00371 |
DEGS2 | 4.323 | 0.832 | 0.958 | 0.701 | 0.858 | - | 0.974 | Mlig455_041538 {REF} {Length: 1966} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.6]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=5e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=308, Expect=2e-103]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=6e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=5e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=4e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=7e-143]} {RNA1310_20672.2} {RNA815_19986} Mlig455_053099 {REF} {Length: 2009} {Pfam: Fatty acid desaturase [PF00487.26, score=87.9]; Sphingolipid Delta4-desaturase (DES) [PF08557.12, score=57.5]} {Human: ENSG00000168350, DEGS2, delta 4-desaturase, sphingolipid 2, [Score=319, Expect=2e-107]; ENSG00000143753, DEGS1, delta 4-desaturase, sphingolipid 1, [Score=315, Expect=4e-106]} {Mouse: ENSMUSG00000038633, Degs1, delta(4)-desaturase, sphingolipid 1, [Score=309, Expect=7e-104]; ENSMUSG00000021263, Degs2, delta(4)-desaturase, sphingolipid 2, [Score=307, Expect=5e-103]} {Dmel: FBgn0001941, ifc, infertile crescent, [Score=345, Expect=4e-118]} {Celegans: WBGene00017996, F33D4.4, Putative sphingolipid delta(4)-desaturase, [Score=318, Expect=3e-107]} {Smed: dd_Smed_v6_7414_0_1, dd_Smed_v6_7414_0_1, [RH, Score=409, Expect=4e-143]} {RNA1310_20672.1} {RNA815_19986} |
43. | MligTC455_49919 | 745 | 15.52 | Mlig455_017182, Mlig455_048150 | Neo: - Age: - Region-specific R2: 7.180 Region-enriched R2: 7.978/0.00000 Regeneration-downregulated R2: -4.649 Regeneration-depleted R2: -4.649 |
4.309 | 0.708 | 0.749 | - | 0.973 | 0.891 | 0.988 | Mlig455_017182 {REF} {Length: 576} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1310_60849, RNA1509_35830, RNA1509_49816, RNA1509_53987} {RNA1509_35830, RNA1509_49816, RNA1509_53987, RNA815_31347} Mlig455_048150 {REF} {Length: 574} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=24.2]} {RNA1509_35830} {RNA1310_60849} {RNA815_31347} |
|
44. | MligTC455_19248 | 238 | 4.95 | Mlig455_036051 | Neo: - Age: - Region-enriched R2: 8.870/0.00000 |
4.305 | 0.955 | 0.739 | 0.911 | - | 0.719 | 0.981 | Mlig455_036051 {REF} {Length: 807} {RNA1509_57448} {RNA1310_51394} {RNA815_26076} | |
45. | MligTC455_53860 | 202 | 4.22 | Mlig455_053523, Mlig455_061000 | Neo: - Age: Up-Down-Down Region-enriched R2: 3.086/0.02665 |
RGS3 | 4.299 | - | 0.805 | 0.716 | 0.955 | 0.921 | 0.902 | Mlig455_053523 {REF} {Length: 2125} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=9e-51]} {RNA1310_19330.1} {RNA815_18723} Mlig455_061000 {REF} {Length: 2721} {Pfam: Regulator of G protein signaling domain [PF00615.21, score=117.0]; Dehydrin [PF00257.21, score=20.5]} {Human: ENSG00000138835, RGS3, regulator of G protein signaling 3, [RH, Score=163, Expect=4e-45]} {Mouse: ENSMUSG00000059810, Rgs3, regulator of G-protein signaling 3, [RH, Score=165, Expect=2e-45]} {Dmel: FBgn0028743, Dhit, Double hit, [Score=109, Expect=2e-27]} {Celegans: WBGene00004350, rgs-7, Regulator of G-protein signaling rgs-7, [RH, Score=130, Expect=1e-34]} {Smed: dd_Smed_v6_8787_0_1, dd_Smed_v6_8787_0_1, [Score=173, Expect=8e-51]} {RNA1310_19330.1} {RNA815_18723} |
46. | MligTC455_53414 | 331 | 6.9 | Mlig455_053442 | Neo: - Age: - Region-specific R2: 4.308 Region-enriched R2: 3.374/0.00040 |
RP1 | 4.288 | 0.769 | - | 0.790 | 0.861 | 0.913 | 0.955 | Mlig455_053442 {REF} {Length: 1156} {Pfam: PLAT/LH2 domain [PF01477.25, score=155.8]; Doublecortin [PF03607.19, score=103.5]; Embryo-specific protein 3, (ATS3) [PF06232.13, score=22.0]} {Human: ENSG00000104237, RP1, RP1, axonemal microtubule associated, [Score=473, Expect=5e-146]} {Mouse: ENSMUSG00000025900, Rp1, retinitis pigmentosa 1 (human), [Score=454, Expect=1e-136]} {Dmel: FBgn0261387, CG17528, [Score=56.6, Expect=1e-07]} {Celegans: WBGene00006993, zyg-8, Serine/threonine-protein kinase zyg-8, [Score=75.5, Expect=2e-13]} {Smed: dd_Smed_v6_10315_0_2, dd_Smed_v6_10315_0_2, [Score=698, Expect=0.0]} {RNA1509_21828} {RNA1310_33070.1} {RNA815_13802.1} |
47. | MligTC455_20953 | 115 | 2.4 | Mlig455_002904 | Neo: - Age: - Region-enriched R2: 5.041/0.00953 |
4.28 | - | 0.823 | 0.727 | 0.890 | 0.865 | 0.975 | Mlig455_002904 {REF} {Length: 1514} {RNA1310_19276} {RNA815_20827} | |
48. | MligTC455_48604 | 173 | 3.6 | Mlig455_031074 | Neo: - |
4.278 | 0.767 | 0.852 | 0.796 | 0.951 | 0.912 | - | Mlig455_031074 {REF} {Length: 652} {RNA1310_66509} | |
49. | MligTC455_17586 | 579 | 12.07 | Mlig455_029070 | Neo: - Age: - Region-specific R2: 3.959 Region-enriched R2: 2.423/0.00859 Regeneration-downregulated R6: -3.050 Regeneration-depleted R6: -3.050 |
4.27 | 0.827 | - | 0.730 | 0.987 | 0.949 | 0.777 | Mlig455_029070 {REF} {Length: 859} {RNA1509_53221, RNA1509_56226} {RNA1310_52775.1, RNA1509_53221, RNA1509_56226} {RNA1509_53221, RNA1509_56226, RNA815_35656} | |
50. | MligTC455_42484 | 246 | 5.12 | Mlig455_046416 | Neo: - Age: Down-Up-Down Region-specific R2: 4.313 Region-enriched R2: 2.983/0.00930 |
4.269 | 0.835 | 0.784 | - | 0.973 | 0.864 | 0.813 | Mlig455_046416 {REF} {Length: 1006} {RNA1310_40237.1} {RNA815_18246} | |
51. | MligTC455_18599 | 119 | 2.47 | Mlig455_031197 | Neo: - Age: Down-Up-Up Region-enriched R2: 4.553/0.00808 |
4.25 | 0.813 | - | 0.847 | 0.961 | 0.883 | 0.746 | Mlig455_031197 {REF} {Length: 1284} {RNA1310_35452} | |
52. | MligTC455_47197 | 155 | 3.24 | Mlig455_049096, Mlig455_049118 | Neo: - Age: - |
4.25 | 0.820 | 0.986 | 0.728 | 0.779 | 0.937 | - | Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725} |
|
53. | MligTC455_46903 | 255 | 5.3 | Mlig455_040553 | Neo: - Age: - Region-enriched R2: 9.597/0.00026 |
4.249 | 0.933 | 0.757 | 0.996 | 0.770 | 0.793 | - | Mlig455_040553 {REF} {Length: 562} {RNA1509_45949} {RNA1310_70304, RNA1509_45949} {RNA1509_45949, RNA815_37653} | |
54. | MligTC455_21210 | 58 | 1.21 | Mlig455_054815, Mlig455_054824 | Neo: - Age: - |
4.236 | 0.915 | 0.718 | - | 0.926 | 0.701 | 0.976 | Mlig455_054815 {REF} {Length: 1627} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} Mlig455_054824 {REF} {Length: 2264} {Celegans: WBGene00044176, C30G7.2, [Score=80.9, Expect=2e-19]} {Smed: dd_Smed_v6_8948_0_1, dd_Smed_v6_8948_0_1, [RH, Score=90.9, Expect=9e-24]} {RNA1509_36146} {RNA1310_58910} {RNA815_43112} |
|
55. | MligTC455_41106 | 42 | 0.88 | Mlig455_010275 | Neo: - Age: - Region-enriched R2: 5.386/0.03242 |
CALM1 | 4.225 | 0.980 | 0.866 | 0.731 | - | 0.884 | 0.764 | Mlig455_010275 {REF} {Length: 1557} {Pfam: EF hand [PF00036.34, score=32.5]; EF-hand domain pair [PF13499.8, score=30.4]; EF-hand domain [PF13405.8, score=29.3]} {Human: ENSG00000198668, CALM1, calmodulin 1, [Score=67.0, Expect=4e-14]; ENSG00000160014, CALM3, calmodulin 3, [Score=67.0, Expect=4e-14]; ENSG00000143933, CALM2, calmodulin 2, [Score=67.0, Expect=4e-14]} {Mouse: ENSMUSG00000019370, Calm3, calmodulin 3, [Score=67.0, Expect=3e-14]; ENSMUSG00000036438, Calm2, calmodulin 2, [Score=67.0, Expect=3e-14]; ENSMUSG00000001175, Calm1, calmodulin 1, [Score=67.0, Expect=3e-14]; ENSMUSG00000063130, Calml3, calmodulin-like 3, [Score=63.9, Expect=5e-13]} {Dmel: FBgn0000253, Cam, Calmodulin, [Score=66.2, Expect=4e-14]} {Celegans: WBGene00000552, cmd-1, Calmodulin, [Score=66.6, Expect=3e-14]} {Smed: dd_Smed_v6_255_0_1, dd_Smed_v6_255_0_1, [Score=66.6, Expect=2e-14]} {RNA1310_51265} |
56. | MligTC455_42314 | 406 | 8.46 | Mlig455_052727 | Neo: - Age: - Region-enriched R2: 4.230/0.00183 |
4.22 | 0.876 | - | 0.725 | 0.962 | 0.919 | 0.738 | Mlig455_052727 {REF} {Length: 1339} {Pfam: Hyaluronidase protein (HylP) [PF07212.13, score=19.1]} {RNA1509_51722} {RNA1310_50605} {RNA815_15783.1} | |
57. | MligTC455_29586 | 237 | 4.95 | Mlig455_024687, Mlig455_024712 | Neo: - Age: - Region-specific R2: 5.384 Region-enriched R2: 6.584/0.00000 |
4.157 | 0.741 | 0.734 | 0.789 | 0.995 | 0.898 | - | Mlig455_024687 {REF} {Length: 1636} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} Mlig455_024712 {REF} {Length: 1612} {RNA1509_26262} {RNA1310_30838} {RNA815_35621} |
|
58. | MligTC455_25556 | 160 | 3.33 | Mlig455_041382 | Neo: - Age: - Region-specific R2: 5.503 Region-enriched R2: 4.706/0.00082 |
4.13 | - | 0.769 | 0.966 | 0.942 | 0.718 | 0.735 | Mlig455_041382 {REF} {Length: 1197} {RNA1509_55439} {RNA1310_65119, RNA1509_55439} {RNA1509_55439, RNA815_36098.2} | |
59. | MligTC455_29915 | 50 | 1.04 | Mlig455_027934 | Neo: - Age: Down-Up-Up Region-enriched R2: 6.881/0.04464 |
ANGPTL1 | 4.123 | 0.923 | - | 0.705 | 0.705 | 0.814 | 0.976 | Mlig455_027934 {REF} {Length: 2265} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=43.0]} {Human: ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=48.9, Expect=9e-06]} {Dmel: FBgn0031804, CG9500, [Score=53.1, Expect=9e-08]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=49.7, Expect=1e-06]} {RNA1509_53291} {RNA1310_38229.1} {RNA815_10579.1} |
60. | MligTC455_45912 | 1103 | 22.98 | Mlig455_006912 | Neo: - Age: - Region-specific R2: 3.366 Region-enriched R2: 1.790/0.00307 |
4.107 | 0.721 | - | 0.787 | 0.964 | 0.884 | 0.751 | Mlig455_006912 {REF} {Length: 1066} {RNA1509_32903, RNA1509_42927} {RNA1310_38334, RNA1509_42927} {RNA1509_42927, RNA815_18393} | |
61. | MligTC455_44956 | 144 | 2.99 | Mlig455_061510 | Neo: - Age: - |
4.097 | 0.709 | 0.700 | 0.886 | 0.950 | 0.852 | - | Mlig455_061510 {REF} {Length: 493} {Pfam: Pancreatic hormone peptide [PF00159.20, score=31.3]} {Smed: dd_Smed_v6_6375_0_1, dd_Smed_v6_6375_0_1, [RH, Score=47.8, Expect=9e-09]} {RNA1509_17163} {RNA1310_66833.1} {RNA815_41767} | |
62. | MligTC455_15543 | 50 | 1.03 | Mlig455_028167 | Neo: - Age: - Region-enriched R2: 5.866/0.00492 |
ADRA2A | 4.029 | 0.766 | 0.758 | 0.957 | 0.822 | - | 0.726 | Mlig455_028167 {REF} {Length: 2816} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=224.6]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=49.7]; Olfactory receptor [PF13853.8, score=23.0]} {Human: ENSG00000150594, ADRA2A, adrenoceptor alpha 2A, [Score=205, Expect=1e-60]; ENSG00000274286, ADRA2B, adrenoceptor alpha 2B, [Score=199, Expect=1e-58]; ENSG00000149295, DRD2, dopamine receptor D2, [Score=196, Expect=2e-57]} {Mouse: ENSMUSG00000058620, Adra2b, adrenergic receptor, alpha 2b, [Score=209, Expect=2e-62]; ENSMUSG00000033717, Adra2a, adrenergic receptor, alpha 2a, [Score=208, Expect=6e-62]} {Dmel: FBgn0053517, Dop2R, Dopamine 2-like receptor, [Score=197, Expect=2e-55]} {Celegans: WBGene00004777, ser-2, Tyramine receptor Ser-2, [Score=242, Expect=4e-75]} {Smed: dd_Smed_v6_48706_0_1, dd_Smed_v6_48706_0_1, [Score=205, Expect=1e-61]} {RNA1310_29477} |
63. | MligTC455_35103 | 102 | 2.12 | Mlig455_023928 | Neo: - Age: logFC(26M/2M)=-1.570 Region-enriched R2: 8.161/0.00000 |
OPN4 | 3.887 | - | 0.986 | 0.993 | 0.953 | 0.955 | - | Mlig455_023928 {REF} {Length: 2781} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=179.7]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=34.7]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=28.9]; Olfactory receptor [PF13853.8, score=24.6]; Serpentine type 7TM GPCR chemoreceptor Srv [PF10323.11, score=19.1]} {Human: ENSG00000122375, OPN4, opsin 4, [RH, Score=218, Expect=2e-65]} {Mouse: ENSMUSG00000021799, Opn4, opsin 4 (melanopsin), [RH, Score=225, Expect=1e-68]} {Dmel: FBgn0014019, Rh5, Rhodopsin 5, [RH, Score=222, Expect=2e-68]} {Celegans: WBGene00009619, npr-6, NeuroPeptide Receptor family, [Score=91.3, Expect=4e-20]} {Smed: dd_Smed_v6_15036_0_1, dd_Smed_v6_15036_0_1, [RH, Score=520, Expect=0.0]} {RNA1509_41123} {RNA1310_10673, RNA1509_41123} {RNA1509_41123, RNA815_4962} |
64. | MligTC455_49285 | 164 | 3.41 | Mlig455_004486, Mlig455_037380 | Neo: - Age: - Region-specific R2: 6.095 Region-enriched R2: 5.942/0.00244 |
LEF1 | 3.864 | - | 0.976 | - | 0.982 | 0.935 | 0.971 | Mlig455_004486 {REF} {Length: 3612} {Pfam: HMG (high mobility group) box [PF00505.21, score=30.1]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [Score=105, Expect=2e-24]; ENSG00000081059, TCF7, transcription factor 7, [Score=103, Expect=3e-25]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [Score=100, Expect=2e-22]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [Score=105, Expect=6e-25]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [Score=101, Expect=8e-24]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [Score=100, Expect=1e-22]} {Dmel: FBgn0085432, pan, pangolin, [Score=103, Expect=1e-23]} {Celegans: WBGene00004077, pop-1, [Score=82.0, Expect=8e-17]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [Score=114, Expect=3e-29]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} Mlig455_037380 {REF} {Length: 3365} {Pfam: HMG (high mobility group) box [PF00505.21, score=78.7]; HMG-box domain [PF09011.12, score=32.5]} {Human: ENSG00000138795, LEF1, lymphoid enhancer binding factor 1, [RH, Score=156, Expect=1e-43]; ENSG00000152284, TCF7L1, transcription factor 7 like 1, [RH, Score=154, Expect=7e-41]; ENSG00000081059, TCF7, transcription factor 7, [RH, Score=154, Expect=3e-44]; ENSG00000148737, TCF7L2, transcription factor 7 like 2, [RH, Score=150, Expect=6e-44]} {Mouse: ENSMUSG00000027985, Lef1, lymphoid enhancer binding factor 1, [RH, Score=157, Expect=9e-44]; ENSMUSG00000055799, Tcf7l1, transcription factor 7 like 1 (T cell specific, HMG box), [RH, Score=156, Expect=1e-41]; ENSMUSG00000000782, Tcf7, transcription factor 7, T cell specific, [RH, Score=153, Expect=1e-42]} {Dmel: FBgn0085432, pan, pangolin, [RH, Score=155, Expect=1e-40]} {Celegans: WBGene00004077, pop-1, [Score=104, Expect=4e-24]} {Smed: dd_Smed_v6_34144_0_1, dd_Smed_v6_34144_0_1, [RH, Score=165, Expect=2e-48]} {RNA1509_13914} {RNA1310_16097} {RNA815_47141} |
65. | MligTC455_30463 | 95 | 1.98 | Mlig455_000250, Mlig455_058521, Mlig455_058532 | Neo: - Age: - |
3.829 | 0.994 | - | - | 0.981 | 0.893 | 0.961 | Mlig455_000250 {REF} {Length: 1994} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.7]} {RNA1310_59451} {RNA815_40085} Mlig455_058521 {REF} {Length: 1237} {RNA1310_56656} {RNA815_40085} Mlig455_058532 {REF} {Length: 1973} {Pfam: Transcription factor IIA, alpha/beta subunit [PF03153.15, score=19.5]} {RNA1310_59451} {RNA815_40085} |
|
66. | MligTC455_21757 | 26 | 0.53 | Mlig455_057867 | Neo: - Age: - |
3.824 | 0.969 | - | 0.888 | 0.979 | - | 0.988 | Mlig455_057867 {REF} {Length: 284} {NoTransDecoderORF} {RNA1310_117997} | |
67. | MligTC455_14898 | 41 | 0.86 | Mlig455_011988 | Neo: - Age: - |
3.781 | 0.993 | - | 0.901 | - | 0.899 | 0.988 | Mlig455_011988 {REF} {Length: 858} {Pfam: Lectin C-type domain [PF00059.23, score=28.2]} {RNA1509_20946} {RNA1310_48952} {RNA815_4785.1} | |
68. | MligTC455_30634 | 114 | 2.38 | Mlig455_025888 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.750/0.00140 |
3.78 | - | 0.988 | 0.983 | 0.950 | 0.859 | - | Mlig455_025888 {REF} {Length: 5266} {Pfam: Integrase core domain [PF00665.28, score=50.8]; DDE superfamily endonuclease [PF13358.8, score=22.0]} {Smed: dd_Smed_v6_1574_6_72, dd_Smed_v6_1574_6_72, [Score=149, Expect=3e-41]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1} | |
69. | MligTC455_41967 | 159 | 3.32 | Mlig455_017184 | Neo: Int S/G2/M Age: Down-Up-Up Region-enriched R2: 7.330/0.00001 |
3.771 | - | - | 0.879 | 0.961 | 0.944 | 0.987 | Mlig455_017184 {REF} {Length: 1106} {Pfam: Insulin/IGF/Relaxin family [PF00049.20, score=22.0]} {RNA1509_40628} {RNA1310_50753, RNA1509_40628} {RNA1509_40628, RNA815_21607} | |
70. | MligTC455_15353 | 85 | 1.78 | Mlig455_015663, Mlig455_062473 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.265 Region-enriched R2: 9.386/0.02025 |
ARRB1 | 3.77 | - | 0.922 | 0.993 | 0.952 | 0.903 | - | Mlig455_015663 {REF} {Length: 1700} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=68.5]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=52.0]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=261, Expect=1e-83]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=260, Expect=5e-83]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=259, Expect=1e-82]; ENSMUSG00000060890, Arr3, arrestin 3, retinal, [Score=253, Expect=9e-81]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=252, Expect=6e-80]} {Dmel: FBgn0040206, krz, kurtz, [Score=256, Expect=3e-81]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=235, Expect=2e-73]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=321, Expect=4e-106]} {RNA1509_59210} {RNA1310_21679, RNA1509_59210} {RNA1509_59210, RNA815_10578.1} Mlig455_062473 {REF} {Length: 1703} {Pfam: Arrestin (or S-antigen), N-terminal domain [PF00339.31, score=71.8]; Arrestin (or S-antigen), C-terminal domain [PF02752.24, score=57.4]} {Human: ENSG00000137486, ARRB1, arrestin beta 1, [Score=268, Expect=5e-86]; ENSG00000141480, ARRB2, arrestin beta 2, [Score=268, Expect=4e-86]} {Mouse: ENSMUSG00000018909, Arrb1, arrestin, beta 1, [Score=265, Expect=5e-85]; ENSMUSG00000060216, Arrb2, arrestin, beta 2, [Score=260, Expect=5e-83]} {Dmel: FBgn0040206, krz, kurtz, [Score=259, Expect=3e-82]} {Celegans: WBGene00000195, arr-1, Probable beta-arrestin, [Score=239, Expect=8e-75]} {Smed: dd_Smed_v6_5512_0_2, dd_Smed_v6_5512_0_2, [Score=328, Expect=3e-109]} {RNA1509_59210} {RNA1310_21679} {RNA815_10578.1} |
71. | MligTC455_47675 | 2101 | 43.77 | Mlig455_061675, Mlig455_063136 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.812 Region-specific R2: 4.381 Region-enriched R2: 4.099/0.00000 |
CLEC18C | 3.765 | - | 0.916 | - | 0.947 | 0.912 | 0.990 | Mlig455_061675 {REF} {Length: 2392} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.3]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=75.5, Expect=1e-13]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=77.8, Expect=1e-15]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=75.9, Expect=7e-15]} {Celegans: WBGene00003055, lon-1, LONg, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [Score=134, Expect=5e-33]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} Mlig455_063136 {REF} {Length: 2649} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=60.7]} {Human: ENSG00000157335, CLEC18C, C-type lectin domain family 18 member C, [RH, Score=77.8, Expect=1e-14]; ENSG00000140839, CLEC18B, C-type lectin domain family 18 member B, [RH, Score=77.4, Expect=1e-14]; ENSG00000157322, CLEC18A, C-type lectin domain family 18 member A, [RH, Score=77.0, Expect=2e-14]} {Mouse: ENSMUSG00000020213, Glipr1l1, GLI pathogenesis-related 1 like 1, [Score=78.2, Expect=5e-16]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00003055, lon-1, LONg, [Score=63.5, Expect=6e-11]} {Smed: dd_Smed_v6_2021_0_1, dd_Smed_v6_2021_0_1, [RH, Score=136, Expect=3e-34]} {RNA1509_48080} {RNA1310_16102.1} {RNA815_9265} |
72. | MligTC455_16907 | 87 | 1.82 | Mlig455_008705 | Neo: - Age: Down-Up-Down |
SLC17A8 | 3.76 | 0.952 | - | - | 0.947 | 0.884 | 0.977 | Mlig455_008705 {REF} {Length: 1949} {Pfam: Major Facilitator Superfamily [PF07690.18, score=37.9]; SOCE-associated regulatory factor of calcium homoeostasis [PF06682.14, score=19.6]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [Score=213, Expect=1e-65]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [Score=212, Expect=1e-64]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [Score=208, Expect=6e-64]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [Score=215, Expect=1e-67]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [Score=211, Expect=1e-64]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [Score=207, Expect=4e-63]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=196, Expect=1e-58]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=189, Expect=1e-56]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=234, Expect=3e-73]} {RNA1509_38152} {RNA1310_19607.1} {RNA815_14894} |
73. | MligTC455_40714 | 93 | 1.94 | Mlig455_008848 | Neo: - Age: - Region-enriched R2: 5.100/0.02617 |
3.757 | 0.976 | - | - | 0.936 | 0.861 | 0.984 | Mlig455_008848 {REF} {Length: 2258} {RNA1310_21537} {RNA815_13165} | |
74. | MligTC455_46543 | 178 | 3.7 | Mlig455_000344, Mlig455_067946 | Neo: - Age: - Region-specific R2: 6.098 Region-enriched R2: 6.851/0.00000 |
3.754 | 0.990 | - | 0.932 | 0.928 | 0.904 | - | Mlig455_000344 {REF} {Length: 1920} {RNA1310_82457} {RNA815_33120} Mlig455_067946 {REF} {Length: 1217} {RNA1310_99435} |
|
75. | MligTC455_10227 | 76 | 1.59 | Mlig455_023507, Mlig455_023516, Mlig455_023551 | Neo: - Age: - |
3.746 | - | 0.990 | 0.913 | 0.951 | 0.892 | - | Mlig455_023507 {REF} {Length: 1545} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=21.8]} {RNA1310_22533.3} {RNA815_23050} Mlig455_023516 {REF} {Length: 1641} {RNA1310_22533.3} {RNA815_23050} Mlig455_023551 {REF} {Length: 1638} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_26724.1} |
|
76. | MligTC455_10229 | 24 | 0.49 | Mlig455_023615 | Neo: - Age: - |
3.746 | - | 0.991 | 0.913 | 0.951 | 0.891 | - | Mlig455_023615 {REF} {Length: 1635} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=22.2]} {RNA1310_22533.3} {RNA815_23050} | |
77. | MligTC455_23957 | 33 | 0.68 | Mlig455_015196, Mlig455_068736 | Neo: - Age: - Region-enriched R2: 7.683/0.01527 |
3.738 | - | - | 0.976 | 0.984 | 0.790 | 0.988 | Mlig455_015196 {REF} {Length: 1138} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=63.8]} {RNA1509_30941} {RNA1310_34740} {RNA815_15663} Mlig455_068736 {REF} {Length: 1580} {Pfam: Concanavalin A-like lectin/glucanases superfamily [PF13385.8, score=64.0]} {RNA1310_32395.1} {RNA815_15663} |
|
78. | MligTC455_51194 | 408 | 8.5 | Mlig455_007624, Mlig455_007645 | Neo: - Age: - Region-specific R2: 3.993 Region-enriched R2: 3.717/0.00015 |
CDK5R1 | 3.716 | 0.906 | - | - | 0.985 | 0.887 | 0.938 | Mlig455_007624 {REF} {Length: 1990} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.2]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=7e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=6e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=2e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=176, Expect=6e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=215, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} Mlig455_007645 {REF} {Length: 1937} {Pfam: Cyclin-dependent kinase 5 activator protein [PF03261.17, score=249.3]} {Human: ENSG00000176749, CDK5R1, cyclin dependent kinase 5 regulatory subunit 1, [RH, Score=191, Expect=8e-57]} {Mouse: ENSMUSG00000048895, Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35), [RH, Score=191, Expect=5e-57]} {Dmel: FBgn0027491, Cdk5alpha, Cdk5 activator-like protein, [RH, Score=199, Expect=3e-58]} {Celegans: WBGene00011955, cdka-1, Cyclin-dependent kinase 5 activator 1, [RH, Score=177, Expect=2e-51]} {Smed: dd_Smed_v6_13788_0_1, dd_Smed_v6_13788_0_1, [RH, Score=216, Expect=1e-66]} {RNA1509_28436} {RNA1310_14097} {RNA815_13436} |
79. | MligTC455_47110 | 34 | 0.7 | Mlig455_025028 | Neo: - Age: - |
3.715 | - | 0.984 | 0.901 | 0.942 | 0.888 | - | Mlig455_025028 {REF} {Length: 521} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
80. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
3.71 | 0.924 | - | - | 0.978 | 0.820 | 0.988 | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
81. | MligTC455_16908 | 161 | 3.35 | Mlig455_046916 | Neo: - Age: Up-Down-Down, logFC(26M/2M)=-0.397 Region-enriched R2: 2.938/0.02849 |
SLC17A6 | 3.697 | 0.971 | 0.840 | - | 0.943 | - | 0.943 | Mlig455_046916 {REF} {Length: 3198} {Pfam: Major Facilitator Superfamily [PF07690.18, score=172.0]; Uncharacterised MFS-type transporter YbfB [PF06779.16, score=19.6]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=548, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=542, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=536, Expect=0.0]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=551, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=547, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=543, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=482, Expect=6e-163]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=479, Expect=7e-163]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=591, Expect=0.0]} {RNA1509_38152} {RNA1310_23072, RNA1509_38152} {RNA1509_38152, RNA815_14894} |
82. | MligTC455_51807 | 28 | 0.59 | Mlig455_046394 | Neo: - Age: - |
GPSM2 | 3.697 | - | 0.969 | 0.846 | - | 0.908 | 0.974 | Mlig455_046394 {REF} {Length: 3388} {Pfam: Tetratricopeptide repeat [PF13424.8, score=114.4]; Tetratricopeptide repeat [PF13176.8, score=96.0]; Tetratricopeptide repeat [PF00515.30, score=94.3]; GoLoco motif [PF02188.19, score=85.6]; Tetratricopeptide repeat [PF07719.19, score=55.0]; Tetratricopeptide repeat [PF13181.8, score=42.2]; Tetratricopeptide repeat [PF13374.8, score=32.8]; Rapsyn N-terminal myristoylation and linker region [PF10579.11, score=20.1]} {Human: ENSG00000121957, GPSM2, G protein signaling modulator 2, [RH, Score=542, Expect=0.0]} {Mouse: ENSMUSG00000027883, Gpsm2, G-protein signalling modulator 2 (AGS3-like, C. elegans), [RH, Score=532, Expect=1e-180]; ENSMUSG00000026930, Gpsm1, G-protein signalling modulator 1 (AGS3-like, C. elegans), [RH, Score=511, Expect=1e-172]} {Dmel: FBgn0040080, pins, partner of inscuteable, [RH, Score=530, Expect=2e-180]} {Celegans: WBGene00000092, ags-3, Activator of G protein Signalling, [RH, Score=266, Expect=7e-80]} {Smed: dd_Smed_v6_6548_1_1, dd_Smed_v6_6548_1_1, [RH, Score=477, Expect=1e-159]} {RNA1310_18538} {RNA815_41322} |
83. | MligTC455_50778 | 36 | 0.76 | Mlig455_042296 | Neo: - Age: - |
GPR50 | 3.682 | - | - | 0.938 | 0.872 | 0.883 | 0.989 | Mlig455_042296 {REF} {Length: 1415} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=116.3]; Serpentine type 7TM GPCR chemoreceptor Srx [PF10328.11, score=40.0]; Olfactory receptor [PF13853.8, score=34.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=33.9]} {Human: ENSG00000102195, GPR50, G protein-coupled receptor 50, [Score=124, Expect=4e-31]; ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=119, Expect=2e-30]} {Mouse: ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=120, Expect=4e-31]; ENSMUSG00000056380, Gpr50, G-protein-coupled receptor 50, [Score=119, Expect=2e-29]; ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=118, Expect=5e-30]} {Dmel: FBgn0038980, Octbeta1R, Octopamine beta1 receptor, [Score=92.0, Expect=1e-20]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=69.7, Expect=4e-13]} {Smed: dd_Smed_v6_65999_0_1, dd_Smed_v6_65999_0_1, [Score=84.7, Expect=1e-18]} {RNA1310_66047} {RNA815_34066} |
84. | MligTC455_11254 | 19 | 0.4 | Mlig455_060079 | Neo: - Age: - |
3.681 | 0.973 | - | 0.954 | 0.824 | 0.930 | - | Mlig455_060079 {REF} {Length: 1689} {Pfam: Glycine rich protein [PF12810.9, score=20.4]} | |
85. | MligTC455_44725 | 67 | 1.4 | Mlig455_024194 | Neo: - Age: - |
3.679 | - | 0.976 | 0.894 | 0.934 | 0.875 | - | Mlig455_024194 {REF} {Length: 956} {RNA1310_84543} {RNA815_47586} | |
86. | MligTC455_16606 | 108 | 2.26 | Mlig455_034973, Mlig455_053711, Mlig455_060000 | Neo: - Age: - Region-enriched R2: 5.697/0.00617 |
GLRA2 | 3.666 | - | - | 0.963 | 0.942 | 0.852 | 0.909 | Mlig455_034973 {REF} {Length: 1000} {RNA1310_100434} Mlig455_053711 {REF} {Length: 2327} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=60.8, Expect=3e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=61.6, Expect=1e-09]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=6e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1310_56609} {RNA815_37711} Mlig455_060000 {REF} {Length: 2781} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=52.0]} {Human: ENSG00000101958, GLRA2, glycine receptor alpha 2, [Score=62.0, Expect=1e-09]; ENSG00000109738, GLRB, glycine receptor beta, [Score=60.1, Expect=5e-09]} {Mouse: ENSMUSG00000023267, Gabrr2, gamma-aminobutyric acid (GABA) C receptor, subunit rho 2, [Score=62.0, Expect=7e-10]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=62.0, Expect=7e-10]; ENSMUSG00000028020, Glrb, glycine receptor, beta subunit, [Score=61.2, Expect=2e-09]} {Dmel: FBgn0010240, Lcch3, Ligand-gated chloride channel homolog 3, [Score=58.9, Expect=5e-09]} {Celegans: WBGene00001587, ggr-2, GABA/Glycine Receptor family (See gbr), [Score=60.8, Expect=1e-09]} {RNA1509_50322} {RNA1310_56609} {RNA815_37711} |
87. | MligTC455_47259 | 985 | 20.52 | Mlig455_024978 | Neo: - Age: - Region-enriched R2: 2.522/0.00122 |
3.652 | - | 0.957 | 0.926 | 0.887 | 0.882 | - | Mlig455_024978 {REF} {Length: 514} {RNA1310_63739.2} {RNA815_33907} | |
88. | MligTC455_35019 | 168 | 3.49 | Mlig455_046994 | Neo: - Age: - |
ASIC4 | 3.646 | 0.929 | 0.917 | - | 0.845 | - | 0.955 | Mlig455_046994 {REF} {Length: 4001} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=101.4]} {Human: ENSG00000072182, ASIC4, acid sensing ion channel subunit family member 4, [Score=76.3, Expect=1e-13]} {Mouse: ENSMUSG00000033007, Asic4, acid-sensing (proton-gated) ion channel family member 4, [Score=76.3, Expect=8e-14]; ENSMUSG00000023017, Asic1, acid-sensing (proton-gated) ion channel 1, [Score=72.8, Expect=8e-13]} {Smed: dd_Smed_v6_15233_0_1, dd_Smed_v6_15233_0_1, [RH, Score=103, Expect=1e-22]} {RNA1509_33816} {RNA1310_3176, RNA1509_33816} {RNA1509_33816, RNA815_12439} |
89. | MligTC455_47080 | 362 | 7.54 | Mlig455_037356 | Neo: - Age: - Region-enriched R2: 2.691/0.00566 |
SSUH2 | 3.639 | 0.932 | - | - | 0.944 | 0.785 | 0.978 | Mlig455_037356 {REF} {Length: 1984} {Pfam: DnaJ central domain [PF00684.21, score=20.9]} {Human: ENSG00000125046, SSUH2, ssu-2 homolog (C. elegans), [Score=189, Expect=3e-56]} {Mouse: ENSMUSG00000034387, Ssu2, ssu-2 homolog (C. elegans), [Score=156, Expect=5e-44]} {Celegans: WBGene00013455, ssu-2, Suppressor of Stomatin mutant Uncoordination, [Score=90.9, Expect=7e-20]} {RNA1509_29510} {RNA1310_15488, RNA1509_29510} {RNA1509_29510, RNA815_5650} |
90. | MligTC455_45350 | 92 | 1.93 | Mlig455_024760, Mlig455_058317, Mlig455_068656 | Neo: - Age: Up-Down-Down |
SLC17A6, SLC17A8 | 3.63 | 0.841 | - | - | 0.991 | 0.825 | 0.973 | Mlig455_024760 {REF} {Length: 2935} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_058317 {REF} {Length: 2971} {Pfam: Major Facilitator Superfamily [PF07690.18, score=157.7]} {Human: ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=534, Expect=0.0]; ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=521, Expect=8e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=531, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=526, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=485, Expect=1e-164]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [Score=474, Expect=7e-162]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [Score=585, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} Mlig455_068656 {REF} {Length: 3034} {Pfam: Major Facilitator Superfamily [PF07690.18, score=158.2]} {Human: ENSG00000179520, SLC17A8, solute carrier family 17 member 8, [RH, Score=531, Expect=0.0]; ENSG00000091664, SLC17A6, solute carrier family 17 member 6, [RH, Score=531, Expect=0.0]; ENSG00000104888, SLC17A7, solute carrier family 17 member 7, [RH, Score=522, Expect=5e-180]} {Mouse: ENSMUSG00000019935, Slc17a8, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8, [RH, Score=536, Expect=0.0]; ENSMUSG00000030500, Slc17a6, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6, [RH, Score=530, Expect=0.0]; ENSMUSG00000070570, Slc17a7, solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7, [RH, Score=527, Expect=0.0]} {Dmel: FBgn0031424, VGlut, Vesicular glutamate transporter, [Score=487, Expect=1e-165]} {Celegans: WBGene00001135, eat-4, Probable vesicular glutamate transporter eat-4, [RH, Score=474, Expect=3e-161]} {Smed: dd_Smed_v6_10192_0_1, dd_Smed_v6_10192_0_1, [RH, Score=583, Expect=0.0]} {RNA1310_14405.1} {RNA815_24257} |
91. | MligTC455_11776 | 33 | 0.68 | Mlig455_048959 | Neo: - Age: - |
GABBR2 | 3.625 | - | 0.777 | 0.994 | 0.952 | 0.902 | - | Mlig455_048959 {REF} {Length: 2499} {Pfam: 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=162.7]; Receptor family ligand binding region [PF01094.30, score=94.2]} {Human: ENSG00000136928, GABBR2, gamma-aminobutyric acid type B receptor subunit 2, [Score=277, Expect=2e-80]} {Mouse: ENSMUSG00000039809, Gabbr2, gamma-aminobutyric acid (GABA) B receptor, 2, [Score=273, Expect=5e-79]} {Dmel: FBgn0260446, GABA-B-R1, metabotropic GABA-B receptor subtype 1, [Score=252, Expect=4e-72]} {Celegans: WBGene00021528, gbb-1, GABA B receptor subunit; GABAB1 receptor subunit, [Score=251, Expect=6e-72]} {Smed: dd_Smed_v6_51663_0_1, dd_Smed_v6_51663_0_1, [Score=134, Expect=4e-35]} {RNA1310_72017} {RNA815_50524} |
92. | MligTC455_53333 | 44 | 0.91 | Mlig455_019019, Mlig455_055684 | Neo: - Age: Up-Down-Up Region-enriched R4: 4.725/0.03950 |
CHRNA7 | 3.624 | 0.981 | - | 0.740 | 0.947 | - | 0.956 | Mlig455_019019 {REF} {Length: 2615} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=93.9]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=210, Expect=2e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=207, Expect=8e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=206, Expect=3e-58]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=1e-59]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=205, Expect=3e-58]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=221, Expect=3e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=7e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=426, Expect=5e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} Mlig455_055684 {REF} {Length: 2604} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=154.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=94.7]} {Human: ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=211, Expect=9e-60]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=209, Expect=3e-59]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=208, Expect=5e-59]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=207, Expect=7e-59]} {Mouse: ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=209, Expect=9e-60]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=204, Expect=1e-57]} {Dmel: FBgn0000039, nAChRalpha2, nicotinic Acetylcholine Receptor alpha2, [Score=222, Expect=1e-63]} {Celegans: WBGene00006774, unc-38, Acetylcholine receptor subunit alpha-type unc-38, [Score=190, Expect=6e-53]} {Smed: dd_Smed_v6_9503_0_1, dd_Smed_v6_9503_0_1, [Score=427, Expect=3e-142]} {RNA1509_56207} {RNA1310_26355} {RNA815_26644} |
93. | MligTC455_25072 | 4443 | 92.56 | Mlig455_015899 | Neo: - Age: Down-Down-Down, logFC(26M/2M)=-1.175 Region-enriched R2: 4.389/0.00000 |
PI16 | 3.623 | - | 0.767 | - | 0.948 | 0.943 | 0.965 | Mlig455_015899 {REF} {Length: 2017} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=71.8]} {Human: ENSG00000164530, PI16, peptidase inhibitor 16, [Score=112, Expect=1e-26]} {Mouse: ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [RH, Score=115, Expect=5e-28]} {Dmel: FBgn0038126, CG8483, [Score=95.5, Expect=2e-21]} {Celegans: WBGene00011462, vap-2, Venom-Allergen-like Protein, [RH, Score=85.5, Expect=5e-18]} {Smed: dd_Smed_v6_2512_0_1, dd_Smed_v6_2512_0_1, [Score=140, Expect=2e-39]} {RNA1509_5027} {RNA1310_1356.1} {RNA815_4508} |
94. | MligTC455_50777 | 40 | 0.83 | Mlig455_042072 | Neo: - Age: - |
MTNR1B | 3.621 | - | - | 0.902 | 0.852 | 0.886 | 0.981 | Mlig455_042072 {REF} {Length: 2881} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=78.0]; Olfactory receptor [PF13853.8, score=24.3]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=22.0]} {Human: ENSG00000134640, MTNR1B, melatonin receptor 1B, [Score=94.4, Expect=2e-21]; ENSG00000168412, MTNR1A, melatonin receptor 1A, [Score=90.1, Expect=5e-20]} {Mouse: ENSMUSG00000050901, Mtnr1b, melatonin receptor 1B, [Score=94.0, Expect=2e-21]; ENSMUSG00000054764, Mtnr1a, melatonin receptor 1A, [Score=89.4, Expect=6e-20]} {Dmel: FBgn0004514, Oct-TyrR, Octopamine-Tyramine receptor, [Score=57.0, Expect=7e-09]} {Celegans: WBGene00006428, tkr-3, TachyKinin Receptor family, [Score=52.0, Expect=2e-07]} {Smed: dd_Smed_v6_19535_0_1, dd_Smed_v6_19535_0_1, [Score=95.5, Expect=2e-22]} {RNA1310_66047} {RNA815_34066} |
95. | MligTC455_43261 | 41 | 0.86 | Mlig455_065982 | Neo: - Age: - |
3.62 | - | 0.945 | 0.870 | 0.978 | 0.827 | - | Mlig455_065982 {REF} {Length: 581} {RNA1509_55651} {RNA1310_59019} {RNA815_42240} | |
96. | MligTC455_23220 | 56 | 1.18 | Mlig455_060190 | Neo: - Age: - |
ACKR3 | 3.617 | - | 0.964 | 0.863 | 0.921 | 0.869 | - | Mlig455_060190 {REF} {Length: 2108} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=106.0]} {Human: ENSG00000144476, ACKR3, atypical chemokine receptor 3, [RH, Score=99.0, Expect=1e-22]} {Mouse: ENSMUSG00000026180, Cxcr2, chemokine (C-X-C motif) receptor 2, [Score=112, Expect=1e-27]} {Dmel: FBgn0266429, AstA-R1, Allatostatin A receptor 1, [Score=102, Expect=4e-24]} {Celegans: WBGene00021439, ckr-2, CholecystoKinin Receptor homolog; Cholecystokinin receptor 2 splice isoform b, [Score=68.2, Expect=2e-12]} {Smed: dd_Smed_v6_10325_0_1, dd_Smed_v6_10325_0_1, [Score=81.6, Expect=5e-17]} {RNA1310_66504} {RNA815_39432} |
97. | MligTC455_12512 | 80 | 1.68 | Mlig455_017689 | Neo: - Age: - |
3.612 | 0.771 | - | - | 0.958 | 0.888 | 0.995 | Mlig455_017689 {REF} {Length: 934} {RNA1310_37507} {RNA815_32171} | |
98. | MligTC455_17178 | 54 | 1.12 | Mlig455_067758 | Neo: - Age: - Region-enriched R2: 7.471/0.00007 |
3.612 | 0.768 | - | - | 0.968 | 0.895 | 0.981 | Mlig455_067758 {REF} {Length: 2301} {RNA1509_44702} {RNA1310_14743} {RNA815_20669.1} | |
99. | MligTC455_14216 | 241 | 5.03 | Mlig455_044260 | Neo: - Age: Up-Down-Up Region-enriched R2: 6.597/0.00013 |
DBH | 3.611 | - | - | 0.964 | 0.834 | 0.881 | 0.932 | Mlig455_044260 {REF} {Length: 840} {Pfam: Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=26.2]} {Human: ENSG00000123454, DBH, dopamine beta-hydroxylase, [Score=70.9, Expect=4e-15]} {Mouse: ENSMUSG00000000889, Dbh, dopamine beta hydroxylase, [Score=72.0, Expect=1e-15]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=64.7, Expect=3e-13]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=52.4, Expect=5e-09]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=65.1, Expect=1e-13]} {RNA1509_17014} {RNA1310_13801} {RNA815_8852} |
100. | MligTC455_41382 | 65 | 1.35 | Mlig455_022554 | Neo: - Age: - Region-enriched R2: 5.596/0.01432 |
3.61 | 0.771 | - | - | 0.971 | 0.880 | 0.988 | Mlig455_022554 {REF} {Length: 503} {Pfam: Pancreatic hormone peptide [PF00159.20, score=18.9]} {RNA1310_81495} {RNA815_42745} |